Skip to Main content Skip to Navigation
Journal articles

DLNO/DLCO ratio evolution under targeted therapy in patients with pulmonary hypertension

Abstract : The ratio of the diffusing capacity of the lung for carbon monoxide (DLCO) and for nitric oxide (DLNO) measured simultaneously is modified in patients with precapillary pulmonary hypertension (PH). The potential impact of targeted therapy on the DLCO/DLNO ratio is unknown. Simultaneous measurements of DLNO and DLCO were performed at baseline, 3-4 month follow-up (first evaluation) and 12-month follow-up (second evaluation) after initiation of targeted PH therapies in incident cases of precapillary PH. The main outcome was the change in DLNO/DLCO ratio under treatment between baseline and the first evaluation. Twenty-nine patients were included (mean age: 66.8 years, 62.1% female). No significant change in the DLNO/DLCO ratio was found between baseline and the first evaluation. Similarly, no significant differences were noted with regard to changes in Dm or Vc, the DLNO/DLCO ratio in different patient subgroups, or in the 20 patients evaluated at the second follow-up. Within the limitations of this study, the DLNO/DLCO ratio is not useful in monitoring the response to treatment in PH.
Complete list of metadata
Contributor : Sabine Rossi <>
Submitted on : Wednesday, December 2, 2020 - 3:29:04 PM
Last modification on : Wednesday, March 31, 2021 - 10:58:21 AM


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Links full text



J. Catella, F. Costes, Jb Gaultier, I. Court Fortune, C. Tulane, et al.. DLNO/DLCO ratio evolution under targeted therapy in patients with pulmonary hypertension. Respiratory Physiology and Neurobiology, Elsevier, 2020, 279, pp.103467. ⟨10.1016/j.resp.2020.103467⟩. ⟨hal-03036197⟩



Record views